Istradefylline clinical trials
Also written KW-6002 and Nourianz.
How each study uses istradefylline is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the istradefylline studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 27 Aug 2019 · NOURIANZ · NDA 022075 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
25 studies that test it; most in 2005 (6); 1 more planned to start later
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2002 | 3 |
| 2004 | 4 |
| 2005 | 6 |
| 2007 | 1 |
| 2009 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 20 · Other 6
Kyowa Kirin Co., Ltd. (11) · Kyowa Kirin, Inc. (9) · University of Florida (2) · Georgetown University (1) · University of Chicago (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · Randy Trumbower, PT, PhD (1)
Studies
Open first, then newest update. How each study uses istradefylline is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 26
- Enhancing Rehabilitation in Aging Study (ERAS)Not yet recruitingPhase 1/2University of FloridaNCT07704385Written as Istradefylline 20 mgHow we know
- Combining Low Oxygen Therapy and an Adenosine A2a Receptor Antagonist to Improve Functional Mobility After Spinal Cord InjuryNot yet recruitingPhase 1/2Randy Trumbower, PT, PhDNCT05217498Written as IstradefyllineHow we know
- Adenosine 2A Receptor Antagonism and AIH in ALSActive, not recruitingPhase 1/2University of FloridaNCT05377424Written as Consume 20mg of istradefyllineHow we know
- Istradefylline Effect Protocol on Parkinson's Disease TremorCompletedPhase 4Georgetown UniversityNCT05885360Written as Istradefylline PillHow we know
- An Extension of Istradefylline in North American Parkinson's Disease Patients Who Have Completed Study 6002-INT-001TerminatedPhase 3Kyowa Kirin, Inc.NCT00199381Written as IstradefyllineHow we know
- Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's DiseaseCompletedPhase 3Kyowa Kirin Co., Ltd.NCT02610231Written as Istradefylline 20 mg or 40 mgHow we know
- A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on LevodopaCompletedPhase 3Kyowa Kirin, Inc.NCT00199420Written as Istradefylline (KW-6002)How we know
- A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's DiseaseCompletedPhase 3Kyowa Kirin Co., Ltd.NCT01968031Written as Istradefylline 40 mgHow we know
- 12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/CarbodopaCompletedPhase 2Kyowa Kirin, Inc.NCT00456794Written as Istradefylline (KW-6002)How we know
- A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's DiseaseCompletedPhase 3Kyowa Kirin Co., Ltd.NCT00199394Written as Istradefylline (KW-6002)How we know
- Study of Istradefylline (KW-6002) for the Treatment of Restless Legs SyndromeCompletedPhase 2Kyowa Kirin, Inc.NCT00199446Written as Istradefylline (KW-6002)How we know
- 12-Week, Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of 40 mg/Day KW-6002 in Parkinson's Disease Patients on Levodopa/CarbidopaCompletedPhase 2Kyowa Kirin, Inc.NCT00456586Written as KW-6002 (istradefylline)How we know
- An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018CompletedPhase 3Kyowa Kirin, Inc.NCT00199368Written as Istradefylline ( KW-6002)How we know
- The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers.CompletedPhase 1Kyowa Kirin Co., Ltd.NCT02174250Written as Istradefylline 40 mgHow we know
- A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking LevodopaCompletedPhase 3Kyowa Kirin, Inc.NCT00199407Written as Istradefylline (KW-6002)How we know
- Effect of Mild Hepatic Impairment on the Pharmacokinetics of IstradefyllineCompletedPhase 1Kyowa Kirin Co., Ltd.NCT02256033Written as IstradefyllineHow we know
- A Long-Term, Safety Study With a Flexible Dose Range of KW-6002 in Patients With Motor Response Complications on Levodopa/Carbidopa TherapyCompletedPhase 2/3Kyowa Kirin, Inc.NCT00955045Written as istradefyllineHow we know
- A Study of Istradefylline (KW-6002) as Monotherapy in Parkinson's Disease (PD) PatientsCompletedPhase 2Kyowa Kirin, Inc.NCT00199433Written as Istradefylline (KW-6002)How we know
- A Study to Evaluate Abuse Potential of IstradefyllineCompletedPhase 1Kyowa Kirin Co., Ltd.NCT02609477Written as IstradefyllineHow we know
- A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking LevodopaCompletedPhase 2Kyowa Kirin Co., Ltd.NCT00199355Written as Istradefylline (KW-6002)How we know
Codes
What other systems call istradefylline · ClinicalTrials.gg INT004063
- MeSH (NLM) C111599istradefyllineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 2GZ0LIK7T4ISTRADEFYLLINEConfirmed FDA, NLM, Wikidata
- RxNorm 2199015One source FDA
- Wikidata Q905783istradefyllineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C73268IstradefyllineOne source FDA
- DrugBank DB11757One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C111599 | istradefylline | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 2GZ0LIK7T4 | ISTRADEFYLLINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2199015 | — | One source FDA |
| Wikidata | Q905783 | istradefylline | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C73268 | Istradefylline | One source FDA |
| DrugBank | DB11757 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.